Treatment for Brain Metastases from EGFR Mutations NSCLC Patients: How Should We Choose in Clinical Practice?
Brain metastasis of epidermal growth factor receptor (EGFR) sensitive mutations is a hot and difficult point in targeted era of non-small cell lung cancer (NSCLC) treatment, meanwhile it is also the central issue of controversy in the field of lung cancer treatment. Different results of different st...
| 發表在: | Chinese Journal of Lung Cancer |
|---|---|
| Main Authors: | , |
| 格式: | Article |
| 語言: | 中文 |
| 出版: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-08-01
|
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.29 |